MDS is a bone marrow failure disorder
MDS is a blood cancer
Learn More >

Welcome to the MDS Patient Message Board Post New Thread

Welcome to the MDS Patient Message Board. We hope that you will find this to be a very valuable resource in your journey. We have recently revised the format of our forum to be much more user friendly and pleasing on the eyes. Let us know if you have any problems, or if you have additional suggestions on how we might further improve our site.


Viewing 3 posts - 1 through 3 (of 3 total)
  • Author
  • #59325
    Joe Catalano

    Has anyone heard ANYTHING? About this?
    Imetelstat Provides Durable Transfusion Independence in Lower-Risk MDS
    Jan 4, 2023
    By Kristi Rosa

    Significant and durable transfusion independence was achieved with imetelstat vs placebo in patients with lower-risk myelodysplastic syndromes who were relapsed, refractory, or ineligible for erythropoiesis-stimulating agents, meeting the primary and a key secondary end point of the phase 3 IMerge trial.


    Hi Joe, Here is a recent press release on Imetelstat:
    Geron Announces Positive Top-Line Results from IMerge Phase 3 Trial of Imetelstat in Lower Risk MDS

    Jimmy Greenhut

    Hi Joe, I’ve been in treatment with the phase 3 trial @ Moffit. Going for my 13th treatment end of the month. Imetelstat did manage to get me from 7 pints a month to almost 8 week transfusion independence. My 11th & 12th treatments I had allergic reaction instantly. It never raised my HGB to bloodlet. Feb 3 pints, March 2 pints. Fatigued, weakness are major issues & gastro. Will see how long I’ll be in the study? FDA is going to approve it in 2024

Viewing 3 posts - 1 through 3 (of 3 total)

Register for an account, or login to post to our message boards. Click here.

  • You must be logged in to reply to this topic.



Search Forums

Review answers to commonly asked questions or get answers to your questions from an MDS expert